June, 07 2026 Sunday 08:33 Hrs
Last update 11-9-2025
  • SENSEX :   74,243.34

  • Top commodity trading and broking companies in India-116.67( -0.16%) 05-Jun-2026
Negative
Sensex 74243.34 -116.67  (-0.16) 05-Jun-2026
Previous Day Close 74360.01
Today's High/Low
High Low
  •  
  •  
74717.57 73988.75

Company News Details

Alivus Life Sciences Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
543322
INE03Q201024
271.4805949
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ALIVUS
21.68
12653.82
EPS(TTM)
Face Value()
Div & Yield %
47.56
2
0.48
 

alivus life sciences ltd
Alivus Life Sciences standalone net profit rises 9.71% in the December 2025 quarter
Jan 22,2026
Net profit of Alivus Life Sciences rose 9.71% to Rs 150.26 crore in the quarter ended December 2025 as against Rs 136.96 crore during the previous quarter ended December 2024. Sales rose 4.84% to Rs 672.89 crore in the quarter ended December 2025 as against Rs 641.84 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales672.89641.84 5
OPM %34.3729.65 -
PBDT243.71200.31 22
PBT224.05185.15 21
NP150.26136.96 10
Top

Attention Investor:

Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers/Depository Participant.     KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, ,Mutual ).    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.